Home/Filings/4/0001127602-24-002024
4//SEC Filing

Li Dean Y 4

Accession 0001127602-24-002024

CIK 0000310158other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:10 PM ET

Size

5.0 KB

Accession

0001127602-24-002024

Insider Transaction Report

Form 4
Period: 2024-01-22
Li Dean Y
Executive VP & President, MRL
Transactions
  • Award

    Common Stock

    2024-01-22$119.43/sh+25,760$3,076,51746,242.37 total
Footnotes (2)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001837016

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:10 PM ET
Size
5.0 KB